Comparison of Clinical Decision Support Tools to Improve Pediatric Lipid Screening

Amir Goren1, Henri C Santos1, Thomas W Davis2

  • 1Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA.

The Journal of Pediatrics
|February 24, 2024
PubMed

Insights

Electronic alerts significantly increased lipid screening orders and completions in children aged 9-11. Clinical decision support tools, particularly alerts, improve guideline-concordant screening rates.

Area of Science:

  • Pediatric Health
  • Clinical Decision Support Systems
  • Preventive Cardiology

Background:

  • Guideline-recommended lipid screening in children is underutilized.
  • Effective strategies are needed to improve adherence to screening guidelines.
  • Clinical decision support (CDS) tools integrated into electronic health records (EHRs) show promise.

Purpose of the Study:

  • To evaluate the effectiveness of different CDS tools in increasing clinician orders and patient completion of lipid screening in pediatric patients.
  • To compare the impact of passive care gap listings versus active alerts, and their combination, against standard practice.

Main Methods:

  • A pragmatic, patient-randomized clinical trial involving 13,346 children aged 9-11 years was conducted within the Geisinger Health System.
  • Four arms were compared: passive care gap listing, active alert panel, combined care gap and alert, and a control group with standard practice.
  • Outcomes measured included clinician orders for lipid screening and patient completion of tests within one week.

Main Results:

  • Patients in active CDS arms (care gap and/or alert) were significantly more likely to have lipid screening ordered and completed compared to the control arm (ORs 1.67-5.73 for orders, 1.54-2.90 for completions).
  • Active alerts, with or without care gap listings, demonstrated superior performance over care gaps alone for increasing screening orders (ORs 2.92-3.43).

Conclusions:

  • Electronic health record-based alerts are effective in increasing both the ordering and completion of lipid screening in pediatric populations.
  • CDS tools, particularly active alerts, can significantly improve guideline-concordant preventive care.
  • Patient randomization within EHRs offers a robust method for assessing the comparative effectiveness of different clinical support interventions.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...